Verve Therapeutics
+$1.23 (+9.10%) As of 3:32 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VERV and other ETFs, options, and stocks.
About VERV
Verve Therapeutics, Inc. is a genetic medicines company engaged in the development of a new approach to the care of cardiovascular disease. It aims to transform treatment from chronic management to single-course gene editing medicines.
CEO
Sekar Kathiresan
Employees
113
Headquarters
Cambridge, Massachusetts
Founded
2018
VERV Key Statistics
Market cap
717.76M
Price-Earnings ratio
—
Dividend yield
—
Average volume
607.74K
High today
$14.75
Low today
$13.28
Open price
$13.50
Volume
133.01K
52 Week high
$78.00
52 Week low
$11.30
Analyst ratings
71%
of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%
VERV Earnings
-$2.13
-$1.42
-$0.71
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, Pre-Market